Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.20421681 |
2 | positive regulation of fatty acid oxidation (GO:0046321) | 4.07378348 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.04018411 |
4 | synaptic vesicle maturation (GO:0016188) | 3.92918462 |
5 | serotonin metabolic process (GO:0042428) | 3.88607309 |
6 | behavioral response to nicotine (GO:0035095) | 3.83367532 |
7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.79339469 |
8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.78553238 |
9 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.71545811 |
10 | plasma membrane repair (GO:0001778) | 3.62713326 |
11 | regulation of sequestering of triglyceride (GO:0010889) | 3.59211359 |
12 | locomotory exploration behavior (GO:0035641) | 3.58973925 |
13 | primary amino compound metabolic process (GO:1901160) | 3.58731041 |
14 | regulation of skeletal muscle contraction (GO:0014819) | 3.53537165 |
15 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.51984327 |
16 | glutamate secretion (GO:0014047) | 3.47991775 |
17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.47151161 |
18 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.45858768 |
19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.42173209 |
20 | synaptic vesicle exocytosis (GO:0016079) | 3.40334207 |
21 | actin-myosin filament sliding (GO:0033275) | 3.36860873 |
22 | muscle filament sliding (GO:0030049) | 3.36860873 |
23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.32768810 |
24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.31542666 |
25 | activation of protein kinase A activity (GO:0034199) | 3.30797992 |
26 | vocalization behavior (GO:0071625) | 3.27678023 |
27 | proline transport (GO:0015824) | 3.22499291 |
28 | membrane depolarization during action potential (GO:0086010) | 3.22252974 |
29 | regulation of membrane repolarization (GO:0060306) | 3.16609025 |
30 | regulation of cell communication by electrical coupling (GO:0010649) | 3.15958566 |
31 | layer formation in cerebral cortex (GO:0021819) | 3.11994632 |
32 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.11742722 |
33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10576618 |
34 | negative regulation of cell killing (GO:0031342) | 3.10576618 |
35 | response to inactivity (GO:0014854) | 3.10081318 |
36 | regulation of synaptic vesicle transport (GO:1902803) | 3.09998591 |
37 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.07845705 |
38 | positive regulation of synapse maturation (GO:0090129) | 3.05334207 |
39 | regulation of synapse structural plasticity (GO:0051823) | 3.02938280 |
40 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.01494315 |
41 | regulation of fatty acid oxidation (GO:0046320) | 2.99320594 |
42 | regulation of ARF protein signal transduction (GO:0032012) | 2.96971931 |
43 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.93121835 |
44 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.92949847 |
45 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.92822164 |
46 | cell differentiation in hindbrain (GO:0021533) | 2.89280557 |
47 | exploration behavior (GO:0035640) | 2.88229893 |
48 | dendrite morphogenesis (GO:0048813) | 2.87793196 |
49 | cellular response to ATP (GO:0071318) | 2.86062482 |
50 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.84714225 |
51 | skeletal muscle contraction (GO:0003009) | 2.83097059 |
52 | neurotransmitter secretion (GO:0007269) | 2.83080706 |
53 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.82398523 |
54 | protein targeting to Golgi (GO:0000042) | 2.80790865 |
55 | regulation of actin filament-based movement (GO:1903115) | 2.79502723 |
56 | relaxation of cardiac muscle (GO:0055119) | 2.79146075 |
57 | cellular potassium ion homeostasis (GO:0030007) | 2.77469882 |
58 | skeletal muscle fiber development (GO:0048741) | 2.77423765 |
59 | neuromuscular synaptic transmission (GO:0007274) | 2.76672404 |
60 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.76661765 |
61 | cerebellar granule cell differentiation (GO:0021707) | 2.75304307 |
62 | striated muscle contraction (GO:0006941) | 2.75298748 |
63 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.75060864 |
64 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.74380230 |
65 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.73948307 |
66 | regulation of relaxation of muscle (GO:1901077) | 2.73065866 |
67 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.71708026 |
68 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.71313843 |
69 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.71121844 |
70 | neuron cell-cell adhesion (GO:0007158) | 2.71032008 |
71 | negative regulation of appetite (GO:0032099) | 2.69640986 |
72 | negative regulation of response to food (GO:0032096) | 2.69640986 |
73 | actin-mediated cell contraction (GO:0070252) | 2.69502563 |
74 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.68493891 |
75 | mating behavior (GO:0007617) | 2.68297564 |
76 | protein localization to synapse (GO:0035418) | 2.67855899 |
77 | detection of calcium ion (GO:0005513) | 2.67516497 |
78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65964197 |
79 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.65570114 |
80 | negative regulation of protein localization to cell surface (GO:2000009) | 2.63418986 |
81 | cardiac muscle contraction (GO:0060048) | 2.63287315 |
82 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.61744673 |
83 | cardiac conduction (GO:0061337) | 2.61724147 |
84 | myofibril assembly (GO:0030239) | 2.61617611 |
85 | regulation of synapse maturation (GO:0090128) | 2.61437925 |
86 | postsynaptic membrane organization (GO:0001941) | 2.60811012 |
87 | sarcomere organization (GO:0045214) | 2.60512856 |
88 | establishment of protein localization to Golgi (GO:0072600) | 2.60258364 |
89 | negative regulation of hormone metabolic process (GO:0032351) | 2.57928547 |
90 | positive regulation of potassium ion transport (GO:0043268) | 2.57696338 |
91 | dendritic spine morphogenesis (GO:0060997) | 2.57633011 |
92 | myotube cell development (GO:0014904) | 2.56268856 |
93 | neuron recognition (GO:0008038) | 2.55626973 |
94 | glutamate receptor signaling pathway (GO:0007215) | 2.52449651 |
95 | gamma-aminobutyric acid transport (GO:0015812) | 2.52279396 |
96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.51226599 |
97 | axonal fasciculation (GO:0007413) | 2.50600914 |
98 | potassium ion homeostasis (GO:0055075) | 2.50409806 |
99 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.50065596 |
100 | membrane depolarization (GO:0051899) | 2.50047873 |
101 | cerebellar Purkinje cell layer development (GO:0021680) | 2.48180852 |
102 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.47297520 |
103 | vesicle transport along microtubule (GO:0047496) | 2.47138577 |
104 | multicellular organismal signaling (GO:0035637) | 2.46946656 |
105 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.46381137 |
106 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.44926707 |
107 | neuronal action potential propagation (GO:0019227) | 2.44397877 |
108 | response to gravity (GO:0009629) | 2.43398675 |
109 | nerve growth factor signaling pathway (GO:0038180) | 2.42535929 |
110 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.41439690 |
111 | pharyngeal system development (GO:0060037) | 2.41411134 |
112 | sodium ion export (GO:0071436) | 2.41144111 |
113 | protein import into peroxisome matrix (GO:0016558) | 2.40705248 |
114 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.38168633 |
115 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.38168633 |
116 | regulation of vesicle fusion (GO:0031338) | 2.37767031 |
117 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.37681934 |
118 | synaptic transmission, glutamatergic (GO:0035249) | 2.37577172 |
119 | neuromuscular process controlling posture (GO:0050884) | 2.37063121 |
120 | alanine transport (GO:0032328) | 2.36309041 |
121 | transmission of nerve impulse (GO:0019226) | 2.35902333 |
122 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.35755279 |
123 | innervation (GO:0060384) | 2.35106454 |
124 | regulation of female receptivity (GO:0045924) | 2.34993082 |
125 | positive regulation of muscle hypertrophy (GO:0014742) | 2.34347834 |
126 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.34347834 |
127 | regulation of dendritic spine development (GO:0060998) | 2.33724570 |
128 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.32896258 |
129 | suckling behavior (GO:0001967) | 2.31658764 |
130 | regulation of postsynaptic membrane potential (GO:0060078) | 2.29564075 |
131 | clathrin coat assembly (GO:0048268) | 2.27121572 |
132 | organelle transport along microtubule (GO:0072384) | 2.26661289 |
133 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.24874776 |
134 | neuron-neuron synaptic transmission (GO:0007270) | 2.23921366 |
135 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.23861436 |
136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.23560695 |
137 | L-phenylalanine catabolic process (GO:0006559) | 2.23560695 |
138 | establishment of nucleus localization (GO:0040023) | 2.22775684 |
139 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.22266095 |
140 | endoplasmic reticulum organization (GO:0007029) | 2.21455431 |
141 | regulation of synaptic plasticity (GO:0048167) | 2.20421719 |
142 | potassium ion import (GO:0010107) | 2.19685045 |
143 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.18772435 |
144 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.17992218 |
145 | neurotransmitter transport (GO:0006836) | 2.16427336 |
146 | presynaptic membrane assembly (GO:0097105) | 2.16401099 |
147 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.16400660 |
148 | cellular sodium ion homeostasis (GO:0006883) | 2.16382295 |
149 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.16308361 |
150 | intraspecies interaction between organisms (GO:0051703) | 2.15282135 |
151 | social behavior (GO:0035176) | 2.15282135 |
152 | cell communication by electrical coupling (GO:0010644) | 2.14770822 |
153 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.13873450 |
154 | long-term memory (GO:0007616) | 2.13215220 |
155 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.11977824 |
156 | neuromuscular process controlling balance (GO:0050885) | 2.11861799 |
157 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.11650237 |
158 | long-term synaptic potentiation (GO:0060291) | 2.11353139 |
159 | female mating behavior (GO:0060180) | 2.10718919 |
160 | inner ear receptor cell development (GO:0060119) | 2.09875471 |
161 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.09851326 |
162 | L-phenylalanine metabolic process (GO:0006558) | 2.09851326 |
163 | prepulse inhibition (GO:0060134) | 2.09460151 |
164 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.09350277 |
165 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.08780477 |
166 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.08233725 |
167 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.08233725 |
168 | regulation of neurotransmitter levels (GO:0001505) | 2.07646703 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.74576746 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.68537852 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32411617 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.24863602 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.17846857 |
6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.10490476 |
7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07429631 |
8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05508387 |
9 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.04115954 |
10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01386971 |
11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.01077773 |
12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00113197 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00113197 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99998342 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97060828 |
16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93150578 |
17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88896964 |
18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85812024 |
19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82928891 |
20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81398186 |
21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80329924 |
22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79958875 |
23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.70128225 |
24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63078254 |
25 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62442290 |
26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61639778 |
27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.60805179 |
28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57333206 |
29 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57315220 |
30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55406070 |
31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55398117 |
32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.54685456 |
33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50713539 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49353242 |
35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47335903 |
36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47042838 |
37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.45190891 |
38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43503702 |
39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42121544 |
40 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.39196734 |
41 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38760797 |
42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37807969 |
43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35602250 |
44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34881865 |
45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33036144 |
46 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32085544 |
47 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.32054320 |
48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31439001 |
49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31165771 |
50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30039624 |
51 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29112214 |
52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28809068 |
53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28223875 |
54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26659347 |
55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26440722 |
56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25414223 |
57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24980070 |
58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23646409 |
59 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21999222 |
60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21548881 |
61 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20387654 |
62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18211049 |
63 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17454162 |
64 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17056265 |
65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16430764 |
66 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15588668 |
67 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14995325 |
68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14586467 |
69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13847799 |
70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13223514 |
71 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13062450 |
72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12696273 |
73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12503174 |
74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11497086 |
75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10276911 |
76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10276911 |
77 | * AR_19668381_ChIP-Seq_PC3_Human | 1.09773534 |
78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08012575 |
79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07502383 |
80 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07306216 |
81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07114711 |
82 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06295617 |
83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06191411 |
84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05903121 |
85 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05304093 |
86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04443456 |
87 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04049714 |
88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.02783853 |
89 | RXR_22108803_ChIP-Seq_LS180_Human | 1.01661395 |
90 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.00815633 |
91 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99548910 |
92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98406825 |
93 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97795032 |
94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97636780 |
95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97354247 |
96 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97247233 |
97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96718840 |
98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96212123 |
99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95479038 |
100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93541170 |
101 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92631520 |
102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92104194 |
103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90242724 |
104 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90173404 |
105 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89560576 |
106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89229856 |
107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88132073 |
108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86239511 |
109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85765329 |
110 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85694206 |
111 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85673328 |
112 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.85583930 |
113 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85234680 |
114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84894932 |
115 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.84757833 |
116 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84593431 |
117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82385183 |
118 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78937086 |
119 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77451841 |
120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74546885 |
121 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.73539210 |
122 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73072422 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 5.40630121 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.08590297 |
3 | MP0003880_abnormal_central_pattern | 3.20529136 |
4 | MP0009780_abnormal_chondrocyte_physiolo | 3.20433008 |
5 | MP0003635_abnormal_synaptic_transmissio | 3.17922299 |
6 | MP0004270_analgesia | 3.00733107 |
7 | MP0002063_abnormal_learning/memory/cond | 2.53613041 |
8 | MP0002837_dystrophic_cardiac_calcinosis | 2.44159151 |
9 | MP0000569_abnormal_digit_pigmentation | 2.37890732 |
10 | MP0009745_abnormal_behavioral_response | 2.34583014 |
11 | MP0005670_abnormal_white_adipose | 2.24415818 |
12 | MP0001968_abnormal_touch/_nociception | 2.19945157 |
13 | MP0003123_paternal_imprinting | 2.12355331 |
14 | MP0002139_abnormal_hepatobiliary_system | 2.11781314 |
15 | MP0002064_seizures | 2.06749659 |
16 | MP0002909_abnormal_adrenal_gland | 2.02018415 |
17 | MP0002572_abnormal_emotion/affect_behav | 1.95185407 |
18 | MP0000013_abnormal_adipose_tissue | 1.83843131 |
19 | MP0004130_abnormal_muscle_cell | 1.82414130 |
20 | MP0001501_abnormal_sleep_pattern | 1.78769525 |
21 | MP0008961_abnormal_basal_metabolism | 1.78105601 |
22 | MP0002877_abnormal_melanocyte_morpholog | 1.77170733 |
23 | MP0001486_abnormal_startle_reflex | 1.75636162 |
24 | MP0005360_urolithiasis | 1.71819702 |
25 | MP0002734_abnormal_mechanical_nocicepti | 1.69406677 |
26 | MP0000751_myopathy | 1.68943207 |
27 | MP0004145_abnormal_muscle_electrophysio | 1.67806480 |
28 | MP0002822_catalepsy | 1.61789969 |
29 | MP0006276_abnormal_autonomic_nervous | 1.60889293 |
30 | MP0004510_myositis | 1.60884044 |
31 | MP0009046_muscle_twitch | 1.59488677 |
32 | MP0005365_abnormal_bile_salt | 1.59144859 |
33 | MP0000749_muscle_degeneration | 1.58864095 |
34 | MP0003329_amyloid_beta_deposits | 1.58321787 |
35 | MP0003300_gastrointestinal_ulcer | 1.57725189 |
36 | MP0002733_abnormal_thermal_nociception | 1.56453206 |
37 | MP0005085_abnormal_gallbladder_physiolo | 1.54710328 |
38 | MP0005187_abnormal_penis_morphology | 1.52749404 |
39 | MP0002106_abnormal_muscle_physiology | 1.51463472 |
40 | MP0002272_abnormal_nervous_system | 1.51226146 |
41 | MP0008775_abnormal_heart_ventricle | 1.48490149 |
42 | MP0001440_abnormal_grooming_behavior | 1.45815830 |
43 | MP0001485_abnormal_pinna_reflex | 1.45671445 |
44 | MP0003045_fibrosis | 1.42611042 |
45 | MP0005535_abnormal_body_temperature | 1.36094771 |
46 | MP0001970_abnormal_pain_threshold | 1.35789292 |
47 | MP0003633_abnormal_nervous_system | 1.34996856 |
48 | MP0004134_abnormal_chest_morphology | 1.34659877 |
49 | MP0000733_abnormal_muscle_development | 1.33943516 |
50 | MP0010329_abnormal_lipoprotein_level | 1.33336416 |
51 | MP0004087_abnormal_muscle_fiber | 1.33146415 |
52 | MP0004924_abnormal_behavior | 1.32605547 |
53 | MP0005386_behavior/neurological_phenoty | 1.32605547 |
54 | MP0005423_abnormal_somatic_nervous | 1.30997903 |
55 | MP0002876_abnormal_thyroid_physiology | 1.30239155 |
56 | MP0005646_abnormal_pituitary_gland | 1.30158657 |
57 | MP0005369_muscle_phenotype | 1.29518133 |
58 | MP0002067_abnormal_sensory_capabilities | 1.28090817 |
59 | MP0004742_abnormal_vestibular_system | 1.27770406 |
60 | MP0005666_abnormal_adipose_tissue | 1.27510879 |
61 | MP0004043_abnormal_pH_regulation | 1.27448364 |
62 | MP0008569_lethality_at_weaning | 1.26879376 |
63 | MP0000537_abnormal_urethra_morphology | 1.25868453 |
64 | MP0000759_abnormal_skeletal_muscle | 1.24145773 |
65 | MP0004858_abnormal_nervous_system | 1.23036474 |
66 | MP0001502_abnormal_circadian_rhythm | 1.23009000 |
67 | MP0002557_abnormal_social/conspecific_i | 1.22506586 |
68 | MP0002735_abnormal_chemical_nociception | 1.19946369 |
69 | MP0004811_abnormal_neuron_physiology | 1.19022024 |
70 | MP0003122_maternal_imprinting | 1.17813218 |
71 | MP0004085_abnormal_heartbeat | 1.11567445 |
72 | MP0010386_abnormal_urinary_bladder | 1.10141395 |
73 | MP0002078_abnormal_glucose_homeostasis | 1.09758783 |
74 | MP0003195_calcinosis | 1.09118058 |
75 | MP0002972_abnormal_cardiac_muscle | 1.07133957 |
76 | MP0001905_abnormal_dopamine_level | 1.06864239 |
77 | MP0002736_abnormal_nociception_after | 1.06440604 |
78 | MP0005623_abnormal_meninges_morphology | 1.06201164 |
79 | MP0003868_abnormal_feces_composition | 1.05163622 |
80 | MP0000750_abnormal_muscle_regeneration | 1.05159957 |
81 | MP0004885_abnormal_endolymph | 1.05145341 |
82 | MP0005167_abnormal_blood-brain_barrier | 1.04811420 |
83 | MP0003690_abnormal_glial_cell | 1.04189222 |
84 | MP0003011_delayed_dark_adaptation | 1.03481022 |
85 | MP0004084_abnormal_cardiac_muscle | 1.03442548 |
86 | MP0004215_abnormal_myocardial_fiber | 1.02545626 |
87 | MP0000747_muscle_weakness | 1.02402087 |
88 | MP0009384_cardiac_valve_regurgitation | 1.01888715 |
89 | MP0000604_amyloidosis | 1.01497219 |
90 | MP0009250_abnormal_appendicular_skeleto | 1.01173530 |
91 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01016996 |
92 | MP0003303_peritoneal_inflammation | 1.00650009 |
93 | MP0003787_abnormal_imprinting | 0.99393224 |
94 | MP0000778_abnormal_nervous_system | 0.99222107 |
95 | MP0003121_genomic_imprinting | 0.99024232 |
96 | MP0003252_abnormal_bile_duct | 0.98721715 |
97 | MP0002971_abnormal_brown_adipose | 0.98272104 |
98 | MP0004036_abnormal_muscle_relaxation | 0.98069581 |
99 | MP0003879_abnormal_hair_cell | 0.94015175 |
100 | MP0008874_decreased_physiological_sensi | 0.93386079 |
101 | MP0002118_abnormal_lipid_homeostasis | 0.92935394 |
102 | MP0001963_abnormal_hearing_physiology | 0.92280871 |
103 | MP0005620_abnormal_muscle_contractility | 0.91740419 |
104 | MP0002066_abnormal_motor_capabilities/c | 0.91475161 |
105 | MP0000955_abnormal_spinal_cord | 0.90908242 |
106 | MP0003172_abnormal_lysosome_physiology | 0.90040627 |
107 | MP0000631_abnormal_neuroendocrine_gland | 0.89897813 |
108 | MP0004142_abnormal_muscle_tone | 0.89119834 |
109 | MP0002184_abnormal_innervation | 0.89085947 |
110 | MP0003631_nervous_system_phenotype | 0.89069552 |
111 | MP0000003_abnormal_adipose_tissue | 0.88405540 |
112 | MP0003183_abnormal_peptide_metabolism | 0.87553223 |
113 | MP0002249_abnormal_larynx_morphology | 0.86861827 |
114 | MP0004133_heterotaxia | 0.84687653 |
115 | MP0001944_abnormal_pancreas_morphology | 0.82920527 |
116 | MP0001299_abnormal_eye_distance/ | 0.82571561 |
117 | MP0004484_altered_response_of | 0.82400239 |
118 | MP0001544_abnormal_cardiovascular_syste | 0.82227149 |
119 | MP0005385_cardiovascular_system_phenoty | 0.82227149 |
120 | MP0005375_adipose_tissue_phenotype | 0.81743294 |
121 | MP0000639_abnormal_adrenal_gland | 0.81565417 |
122 | MP0005334_abnormal_fat_pad | 0.81555032 |
123 | MP0001765_abnormal_ion_homeostasis | 0.81333437 |
124 | MP0000534_abnormal_ureter_morphology | 0.80950914 |
125 | MP0001984_abnormal_olfaction | 0.80857679 |
126 | MP0003283_abnormal_digestive_organ | 0.80418837 |
127 | MP0001986_abnormal_taste_sensitivity | 0.79918047 |
128 | MP0002693_abnormal_pancreas_physiology | 0.79914450 |
129 | MP0002160_abnormal_reproductive_system | 0.78931017 |
130 | MP0002108_abnormal_muscle_morphology | 0.78919364 |
131 | MP0002138_abnormal_hepatobiliary_system | 0.78747316 |
132 | MP0000026_abnormal_inner_ear | 0.78448169 |
133 | MP0003075_altered_response_to | 0.78246800 |
134 | MP0002090_abnormal_vision | 0.78040855 |
135 | MP0004185_abnormal_adipocyte_glucose | 0.77185652 |
136 | MP0003638_abnormal_response/metabolism_ | 0.76098226 |
137 | MP0000681_abnormal_thyroid_gland | 0.75759931 |
138 | MP0002069_abnormal_eating/drinking_beha | 0.74126378 |
139 | MP0000230_abnormal_systemic_arterial | 0.73386146 |
140 | MP0005551_abnormal_eye_electrophysiolog | 0.71823641 |
141 | MP0005330_cardiomyopathy | 0.70003689 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 5.09921783 |
2 | Nemaline bodies (HP:0003798) | 4.86681902 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.80520904 |
4 | Cutaneous melanoma (HP:0012056) | 4.66890798 |
5 | Type 1 muscle fiber predominance (HP:0003803) | 4.28336484 |
6 | Focal motor seizures (HP:0011153) | 4.26420092 |
7 | Diplopia (HP:0000651) | 3.95379785 |
8 | Abnormality of binocular vision (HP:0011514) | 3.95379785 |
9 | Bundle branch block (HP:0011710) | 3.68172174 |
10 | Focal seizures (HP:0007359) | 3.52998831 |
11 | Myotonia (HP:0002486) | 3.50498784 |
12 | Asymmetric septal hypertrophy (HP:0001670) | 3.49337107 |
13 | Myokymia (HP:0002411) | 3.38969839 |
14 | Exercise-induced muscle cramps (HP:0003710) | 3.38509324 |
15 | Visual hallucinations (HP:0002367) | 3.26447878 |
16 | Meningioma (HP:0002858) | 3.20028862 |
17 | Abnormality of the calf musculature (HP:0001430) | 3.16332536 |
18 | Epileptic encephalopathy (HP:0200134) | 3.15765318 |
19 | Ulnar deviation of the wrist (HP:0003049) | 3.06389958 |
20 | Sudden death (HP:0001699) | 3.03839484 |
21 | Hypoglycemic seizures (HP:0002173) | 2.95034634 |
22 | Hyperventilation (HP:0002883) | 2.89465760 |
23 | Papilledema (HP:0001085) | 2.88039157 |
24 | Generalized tonic-clonic seizures (HP:0002069) | 2.86568358 |
25 | Myoglobinuria (HP:0002913) | 2.83499279 |
26 | Absence seizures (HP:0002121) | 2.83404515 |
27 | Ventricular fibrillation (HP:0001663) | 2.78850038 |
28 | Atonic seizures (HP:0010819) | 2.74976506 |
29 | Supranuclear gaze palsy (HP:0000605) | 2.70747482 |
30 | EMG: myopathic abnormalities (HP:0003458) | 2.70678935 |
31 | Distal arthrogryposis (HP:0005684) | 2.70652896 |
32 | Hyperthyroidism (HP:0000836) | 2.70492918 |
33 | Ketoacidosis (HP:0001993) | 2.66398642 |
34 | Goiter (HP:0000853) | 2.66343334 |
35 | Muscle fiber splitting (HP:0003555) | 2.66166636 |
36 | Syncope (HP:0001279) | 2.65428042 |
37 | Exercise-induced myalgia (HP:0003738) | 2.65082844 |
38 | Absent phalangeal crease (HP:0006109) | 2.65055382 |
39 | Poor eye contact (HP:0000817) | 2.63385226 |
40 | Impaired social interactions (HP:0000735) | 2.61447512 |
41 | Abnormal social behavior (HP:0012433) | 2.61447512 |
42 | Obstructive sleep apnea (HP:0002870) | 2.58746496 |
43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.58306656 |
44 | Broad-based gait (HP:0002136) | 2.54267355 |
45 | Deep venous thrombosis (HP:0002625) | 2.51294506 |
46 | Macroorchidism (HP:0000053) | 2.50697340 |
47 | Agitation (HP:0000713) | 2.49879529 |
48 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.49836309 |
49 | Subaortic stenosis (HP:0001682) | 2.49836309 |
50 | Methylmalonic acidemia (HP:0002912) | 2.49037420 |
51 | Excessive salivation (HP:0003781) | 2.47978124 |
52 | Drooling (HP:0002307) | 2.47978124 |
53 | Conjunctival hamartoma (HP:0100780) | 2.46543474 |
54 | Action tremor (HP:0002345) | 2.45939960 |
55 | Febrile seizures (HP:0002373) | 2.44248585 |
56 | Hemiparesis (HP:0001269) | 2.44005567 |
57 | Insidious onset (HP:0003587) | 2.43907276 |
58 | Termporal pattern (HP:0011008) | 2.43907276 |
59 | Dialeptic seizures (HP:0011146) | 2.39186853 |
60 | Depression (HP:0000716) | 2.38970142 |
61 | Round ear (HP:0100830) | 2.38518020 |
62 | Ketosis (HP:0001946) | 2.34991377 |
63 | Cerebral inclusion bodies (HP:0100314) | 2.34695748 |
64 | Rhabdomyolysis (HP:0003201) | 2.34474920 |
65 | Dysmetria (HP:0001310) | 2.34072623 |
66 | Neurofibrillary tangles (HP:0002185) | 2.34066700 |
67 | Hamartoma of the eye (HP:0010568) | 2.31030541 |
68 | Scanning speech (HP:0002168) | 2.31021333 |
69 | Anxiety (HP:0000739) | 2.30735462 |
70 | Hyperkalemia (HP:0002153) | 2.29556590 |
71 | Lymphangioma (HP:0100764) | 2.29355059 |
72 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.28599469 |
73 | EMG: neuropathic changes (HP:0003445) | 2.26819473 |
74 | Neck muscle weakness (HP:0000467) | 2.26248929 |
75 | Epileptiform EEG discharges (HP:0011182) | 2.25096014 |
76 | Incomplete penetrance (HP:0003829) | 2.24393858 |
77 | Abnormal finger flexion creases (HP:0006143) | 2.22972075 |
78 | Confusion (HP:0001289) | 2.22968610 |
79 | Heart block (HP:0012722) | 2.22565856 |
80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19705096 |
81 | Oligomenorrhea (HP:0000876) | 2.19304716 |
82 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17149021 |
83 | Mutism (HP:0002300) | 2.17032331 |
84 | Truncal ataxia (HP:0002078) | 2.16416904 |
85 | Urinary urgency (HP:0000012) | 2.16359031 |
86 | Progressive cerebellar ataxia (HP:0002073) | 2.16153402 |
87 | Fetal akinesia sequence (HP:0001989) | 2.13556556 |
88 | Hyperglycemia (HP:0003074) | 2.13484021 |
89 | Intention tremor (HP:0002080) | 2.13325286 |
90 | Abnormal eating behavior (HP:0100738) | 2.11867895 |
91 | Xanthomatosis (HP:0000991) | 2.11809467 |
92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.11131139 |
93 | Areflexia of lower limbs (HP:0002522) | 2.10858031 |
94 | Blue irides (HP:0000635) | 2.08546668 |
95 | Hypsarrhythmia (HP:0002521) | 2.07652088 |
96 | Abnormality of the axillary hair (HP:0100134) | 2.07443678 |
97 | Abnormality of secondary sexual hair (HP:0009888) | 2.07443678 |
98 | Amblyopia (HP:0000646) | 2.07434298 |
99 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.06992801 |
100 | Short 1st metacarpal (HP:0010034) | 2.06992801 |
101 | Dysdiadochokinesis (HP:0002075) | 2.06937210 |
102 | Bone cyst (HP:0012062) | 2.06731775 |
103 | Ventricular arrhythmia (HP:0004308) | 2.06507909 |
104 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.06309725 |
105 | Ankle clonus (HP:0011448) | 2.06306000 |
106 | Frequent falls (HP:0002359) | 2.03628638 |
107 | Calf muscle hypertrophy (HP:0008981) | 2.03604991 |
108 | Skin nodule (HP:0200036) | 2.03322553 |
109 | Symptomatic seizures (HP:0011145) | 2.03296868 |
110 | Hemiplegia (HP:0002301) | 2.02479879 |
111 | Congenital sensorineural hearing impairment (HP:0008527) | 2.01495147 |
112 | Epidermoid cyst (HP:0200040) | 2.00545886 |
113 | Status epilepticus (HP:0002133) | 2.00026017 |
114 | Type II lissencephaly (HP:0007260) | 1.99409829 |
115 | Abnormal atrioventricular conduction (HP:0005150) | 1.99344562 |
116 | Generalized hypopigmentation of hair (HP:0011358) | 1.99159272 |
117 | Abnormality of the common coagulation pathway (HP:0010990) | 1.98890668 |
118 | Torticollis (HP:0000473) | 1.97032090 |
119 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96949199 |
120 | Methylmalonic aciduria (HP:0012120) | 1.95138642 |
121 | Prolonged partial thromboplastin time (HP:0003645) | 1.94597431 |
122 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92480077 |
123 | Myopathic facies (HP:0002058) | 1.91267698 |
124 | Muscle stiffness (HP:0003552) | 1.90743799 |
125 | Neonatal onset (HP:0003623) | 1.90061921 |
126 | Hip contracture (HP:0003273) | 1.89809362 |
127 | Akinesia (HP:0002304) | 1.87442056 |
128 | Postural instability (HP:0002172) | 1.86349583 |
129 | Abnormality of the corticospinal tract (HP:0002492) | 1.86073671 |
130 | Abnormality of the periventricular white matter (HP:0002518) | 1.85985027 |
131 | Scapular winging (HP:0003691) | 1.85301336 |
132 | Impaired smooth pursuit (HP:0007772) | 1.84863524 |
133 | Prolonged QT interval (HP:0001657) | 1.84327248 |
134 | Clumsiness (HP:0002312) | 1.83605320 |
135 | Lower limb amyotrophy (HP:0007210) | 1.82894721 |
136 | Short femoral neck (HP:0100864) | 1.82598826 |
137 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81947565 |
138 | Mucopolysacchariduria (HP:0008155) | 1.81947565 |
139 | Complement deficiency (HP:0004431) | 1.80687705 |
140 | Limited hip movement (HP:0008800) | 1.80624413 |
141 | Difficulty running (HP:0009046) | 1.80390849 |
142 | Abnormality of the Achilles tendon (HP:0005109) | 1.79777805 |
143 | Subacute progressive viral hepatitis (HP:0006572) | 1.79240855 |
144 | Gaze-evoked nystagmus (HP:0000640) | 1.77403843 |
145 | Genetic anticipation (HP:0003743) | 1.77323015 |
146 | Inappropriate behavior (HP:0000719) | 1.76807470 |
147 | Cerebral hemorrhage (HP:0001342) | 1.76310671 |
148 | Hyporeflexia of lower limbs (HP:0002600) | 1.76045402 |
149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75467620 |
150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75467620 |
151 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75467620 |
152 | Resting tremor (HP:0002322) | 1.75288548 |
153 | Distal lower limb muscle weakness (HP:0009053) | 1.75174838 |
154 | Hypoventilation (HP:0002791) | 1.74020261 |
155 | Hepatoblastoma (HP:0002884) | 1.73277132 |
156 | Abnormal EKG (HP:0003115) | 1.72791714 |
157 | Turricephaly (HP:0000262) | 1.72775581 |
158 | Abnormality of the 1st metacarpal (HP:0010009) | 1.72712551 |
159 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70980012 |
160 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.70675772 |
161 | Lower limb muscle weakness (HP:0007340) | 1.69890634 |
162 | Polyphagia (HP:0002591) | 1.69510884 |
163 | Abnormality of the lower motor neuron (HP:0002366) | 1.69324292 |
164 | Neuronal loss in central nervous system (HP:0002529) | 1.69304593 |
165 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.68856545 |
166 | Hyperlipoproteinemia (HP:0010980) | 1.68430029 |
167 | Progressive inability to walk (HP:0002505) | 1.67781819 |
168 | Absent speech (HP:0001344) | 1.67567749 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 4.31792368 |
2 | MAP3K9 | 3.39119146 |
3 | MAP3K4 | 3.03225847 |
4 | NTRK3 | 2.82844578 |
5 | EPHA4 | 2.67350734 |
6 | MAP3K2 | 2.51483805 |
7 | AKT3 | 2.48967796 |
8 | MAP2K4 | 2.25315863 |
9 | MARK1 | 2.23988377 |
10 | KSR2 | 2.14560393 |
11 | RIPK4 | 2.12286850 |
12 | PRKD2 | 2.12035383 |
13 | DAPK2 | 2.11165234 |
14 | PRKD3 | 1.87714671 |
15 | MAP2K7 | 1.80768887 |
16 | GRK1 | 1.77845018 |
17 | NTRK1 | 1.75070999 |
18 | MINK1 | 1.73351591 |
19 | PAK6 | 1.69541190 |
20 | INSRR | 1.64884003 |
21 | TRIB3 | 1.57169913 |
22 | RET | 1.53729496 |
23 | NTRK2 | 1.43513768 |
24 | CAMK1G | 1.42730240 |
25 | PHKG1 | 1.38044976 |
26 | PHKG2 | 1.38044976 |
27 | PIK3CA | 1.33895241 |
28 | TAOK3 | 1.30402702 |
29 | HIPK2 | 1.27390790 |
30 | MAP3K13 | 1.25858446 |
31 | MAP3K6 | 1.25245261 |
32 | CAMKK1 | 1.24581272 |
33 | KSR1 | 1.24107266 |
34 | SIK2 | 1.23552763 |
35 | CDK5 | 1.21351509 |
36 | PRKCH | 1.18879221 |
37 | DMPK | 1.12806585 |
38 | FES | 1.12762176 |
39 | TYRO3 | 1.11711872 |
40 | ADRBK2 | 1.08351968 |
41 | RIPK1 | 1.07520990 |
42 | MAP3K1 | 1.04744185 |
43 | EPHA3 | 1.01227852 |
44 | ICK | 1.01188812 |
45 | GRK5 | 1.00959828 |
46 | TAOK1 | 1.00578912 |
47 | NEK9 | 0.99269613 |
48 | STK39 | 0.99100470 |
49 | CAMKK2 | 0.98458675 |
50 | MARK2 | 0.96171595 |
51 | PAK3 | 0.95900216 |
52 | PDGFRA | 0.91329702 |
53 | PDK1 | 0.91011583 |
54 | STK11 | 0.89547632 |
55 | CAMK1D | 0.87846019 |
56 | PDPK1 | 0.87644609 |
57 | LATS1 | 0.87035195 |
58 | TNK2 | 0.86635852 |
59 | FER | 0.85972767 |
60 | TAOK2 | 0.85605087 |
61 | SGK3 | 0.84535446 |
62 | MAP3K12 | 0.84330047 |
63 | CSNK1G2 | 0.84062013 |
64 | MAPK4 | 0.82366720 |
65 | DAPK1 | 0.81482018 |
66 | MAPKAPK3 | 0.81435480 |
67 | JAK1 | 0.81182073 |
68 | MAP3K7 | 0.80672830 |
69 | CAMK2A | 0.80496867 |
70 | STK38 | 0.77585298 |
71 | MAPK13 | 0.75334334 |
72 | LATS2 | 0.74775921 |
73 | FGFR3 | 0.74619552 |
74 | SGK2 | 0.74502628 |
75 | FGFR2 | 0.73756897 |
76 | CAMK2G | 0.72926119 |
77 | UHMK1 | 0.72617149 |
78 | MAPK12 | 0.72596642 |
79 | SGK223 | 0.72038369 |
80 | SGK494 | 0.72038369 |
81 | BMPR2 | 0.71993303 |
82 | JAK2 | 0.71835196 |
83 | FRK | 0.70861727 |
84 | SGK1 | 0.68674299 |
85 | FGFR4 | 0.68172205 |
86 | EEF2K | 0.64236098 |
87 | PRKCG | 0.64209490 |
88 | WNK1 | 0.63376880 |
89 | PIK3CG | 0.62950454 |
90 | MOS | 0.60821042 |
91 | MUSK | 0.58808750 |
92 | FGR | 0.58373737 |
93 | SIK1 | 0.57480423 |
94 | ERBB2 | 0.57399576 |
95 | MAPK7 | 0.57368845 |
96 | PTK2B | 0.56569347 |
97 | PLK2 | 0.56471330 |
98 | PDGFRB | 0.55802019 |
99 | CAMK1 | 0.55745590 |
100 | LMTK2 | 0.55733455 |
101 | CAMK4 | 0.55729320 |
102 | PINK1 | 0.55684501 |
103 | RPS6KA2 | 0.54677660 |
104 | PRKD1 | 0.54191163 |
105 | PKN2 | 0.53890926 |
106 | ARAF | 0.53612437 |
107 | MAP3K11 | 0.52894627 |
108 | CAMK2D | 0.52750105 |
109 | CDC42BPA | 0.50977091 |
110 | CDK19 | 0.50739353 |
111 | TIE1 | 0.50527810 |
112 | MAPKAPK5 | 0.49941342 |
113 | CASK | 0.49929953 |
114 | WNK4 | 0.48594504 |
115 | MAP2K1 | 0.48342688 |
116 | PRKACA | 0.47100621 |
117 | PRKAA1 | 0.46881139 |
118 | PTK2 | 0.46721265 |
119 | PRKCE | 0.46720928 |
120 | PTK6 | 0.46544450 |
121 | RPS6KA3 | 0.46004026 |
122 | PRKAA2 | 0.44092003 |
123 | SCYL2 | 0.40355238 |
124 | CAMK2B | 0.39508915 |
125 | PKN1 | 0.39381518 |
126 | TTN | 0.39172405 |
127 | RPS6KB1 | 0.38407881 |
128 | PRKCZ | 0.38057072 |
129 | FYN | 0.37570148 |
130 | MAP2K6 | 0.36867263 |
131 | TRPM7 | 0.35022957 |
132 | MAP2K2 | 0.34310298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.50874003 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 1.92510092 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 1.87181164 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 1.83551452 |
5 | Insulin secretion_Homo sapiens_hsa04911 | 1.82730440 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.82518162 |
7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.80308643 |
8 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.76930002 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.72301865 |
10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69952465 |
11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.69720576 |
12 | Morphine addiction_Homo sapiens_hsa05032 | 1.66964679 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.58578638 |
14 | Renin secretion_Homo sapiens_hsa04924 | 1.58355535 |
15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.57985288 |
16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55647355 |
17 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.52571339 |
18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.48783508 |
19 | Salivary secretion_Homo sapiens_hsa04970 | 1.42416708 |
20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.42318572 |
21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.41886195 |
22 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40432392 |
23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35462747 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29413169 |
25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.29307154 |
26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27967565 |
27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27967136 |
28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27059361 |
29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24056376 |
30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21145680 |
31 | Long-term depression_Homo sapiens_hsa04730 | 1.20462091 |
32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18043527 |
33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16437783 |
34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12870602 |
35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10153887 |
36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06675226 |
37 | Bile secretion_Homo sapiens_hsa04976 | 1.06412727 |
38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05440964 |
39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05321195 |
40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03459005 |
41 | Taste transduction_Homo sapiens_hsa04742 | 1.03329659 |
42 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.01684774 |
43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99181622 |
44 | Glioma_Homo sapiens_hsa05214 | 0.95884670 |
45 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95137937 |
46 | Phototransduction_Homo sapiens_hsa04744 | 0.94425843 |
47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93638125 |
48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91595958 |
49 | Gap junction_Homo sapiens_hsa04540 | 0.91130135 |
50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90084901 |
51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89559927 |
52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88441587 |
53 | Insulin resistance_Homo sapiens_hsa04931 | 0.88300753 |
54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88126681 |
55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85624581 |
56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84603426 |
57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84553637 |
58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83596868 |
59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82544783 |
60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82350744 |
61 | Melanoma_Homo sapiens_hsa05218 | 0.80459587 |
62 | Melanogenesis_Homo sapiens_hsa04916 | 0.79310897 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78911236 |
64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77056640 |
65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70714315 |
66 | Axon guidance_Homo sapiens_hsa04360 | 0.70264437 |
67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69899091 |
68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68081967 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66973366 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66219966 |
71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65733837 |
72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65668098 |
73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65590844 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65172007 |
75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64999465 |
76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64142962 |
77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62945349 |
78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62597367 |
79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62251051 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62107631 |
81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61969302 |
82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60828866 |
83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60568012 |
84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60213558 |
85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59786776 |
86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59223654 |
87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59071513 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58495971 |
89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58367640 |
90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57668253 |
91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57586155 |
92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57178396 |
93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55748524 |
94 | Prion diseases_Homo sapiens_hsa05020 | 0.55476597 |
95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54965995 |
96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54200524 |
97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53944571 |
98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53627792 |
99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51229837 |
100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50553526 |
101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49219961 |
102 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46793525 |
103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46546372 |
104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46394316 |
105 | ABC transporters_Homo sapiens_hsa02010 | 0.45552637 |
106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45312598 |
107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44830018 |
108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44185129 |
109 | Platelet activation_Homo sapiens_hsa04611 | 0.43443233 |
110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43182847 |
111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43095793 |
112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42762031 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42167946 |
114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41913216 |
115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41094651 |
116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41062182 |
117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40891947 |
118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40488327 |
119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40425183 |